Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 7/2018

01-07-2018 | Original Article

Additional lymph node dissection for primary colorectal cancer invading another colon region

Authors: Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Yuji Miyamoto, Naoya Yoshida, Hideo Baba

Published in: Surgery Today | Issue 7/2018

Login to get access

Abstract

Purpose

Surgery remains the curative treatment of choice for colorectal cancer (CRC). However, to our knowledge, no report has addressed the usefulness of additional regional lymph node dissection for primary CRC that has invaded another colon region.

Methods

We reviewed the clinicopathological characteristics and outcomes of eight patients who underwent surgery between March, 2005 and August, 2014, for CRC that invaded another region of the colon.

Results

Five patients underwent additional regional lymph node dissection in the area of the invaded colon and one patient had lymph node metastasis in the region. Two of three patients who did not undergo additional regional lymph node dissection were found to have regional lymph node recurrences in the area during the follow-up period. Although there was no statistical correlation between extra-regional lymph node metastasis and clinicopathological or operative factors, the patients with extra-regional lymph node metastasis or recurrence had primary regional lymph node metastasis.

Conclusion

For curative intent, surgeons may need to perform additional regional lymph node dissection for primary CRC invading another colon region.
Literature
1.
2.
Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729–41.CrossRefPubMed
3.
Booth CM, Nanji S, Wei X, Mackillop WJ. Outcomes of resected colorectal cancer lung metastases in routine clinical practice: a population-based study. Ann Surg Oncol. 2016;23:1057–63.CrossRefPubMed
4.
Choi PW, Kim HC, Kim AY, Jung SH, Yu CS, Kim JC. Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol. 2010;101:66–71.CrossRefPubMed
5.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–16.CrossRefPubMedPubMedCentral
6.
Montesani C, Ribotta G, De Milito R, Pronio A, D’Amato A, Narilli P, et al. Extended resection in the treatment of colorectal cancer. Int J Colorectal Dis. 1991;6:161–4.CrossRefPubMed
7.
Winter DC, Walsh R, Lee G, Kiely D, O’Riordain MG, O’Sullivan GC. Local involvement of the urinary bladder in primary colorectal cancer: outcome with en bloc resection. Ann Surg Oncol. 2007;14:441–6.CrossRefPubMed
8.
The Japanese Society for Cancer of the Colon and Rectum. JSCCR guidelines 2005 for the treatment of colorectal cancer. Tokyo: Kanehara & Co., Ltd.; 2005.
9.
The Japanese Society for Cancer of the Colon and Rectum. JSCCR guidelines 2010 for the treatment of colorectal cancer. Tokyo: Kanehara & Co., Ltd.; 2010.
10.
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.CrossRefPubMed
11.
Sobin LHGM., Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.
12.
13.
Bae SU, Han YD, Cho MS, Hur H, Min BS, Baik SH, et al. Oncologic outcomes of colon cancer patients with extraregional lymph node metastasis: comparison of isolated paraaortic lymph node metastasis with resectable liver metastasis. Ann Surg Oncol. 2016;23:1562–8.CrossRefPubMed
14.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.CrossRefPubMed
15.
Miyakura Y, Iwai H, Togashi K, Horie H, Nagai H, Kishaba Y, et al. Mucinous cystadenocarcinoma of the appendix invading the ascending colon with fistula formation: report of a case. Surg Today. 2007;37:806–10.CrossRefPubMed
16.
Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Inoue H, Yamada K, et al. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241–6.CrossRefPubMed
17.
Laurent C, Sa Cunha A, Rullier E, Smith D, Rullier A, Saric J. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg. 2004;198:884–91.CrossRefPubMed
18.
Viana EF, Herman P, Coelho FF, Taka TA, D’Albuquerque LA, Cecconello I. The role of hilar lymphadenectomy in patients subjected to hepatectomy due to colorectal metastasis. Arq Gastroenterol. 2011;48:217–9.CrossRefPubMed
19.
20.
Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol. 1999;43:S3–10.CrossRefPubMed
21.
Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302–11. (discussion 311–303).PubMedPubMedCentral
22.
Murawa D, Hirche C, Dresel S, Hunerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg. 2009;96:1289–94.CrossRefPubMed
Metadata
Title
Additional lymph node dissection for primary colorectal cancer invading another colon region
Authors
Ryuma Tokunaga
Yasuo Sakamoto
Shigeki Nakagawa
Yuji Miyamoto
Naoya Yoshida
Hideo Baba
Publication date
01-07-2018
Publisher
Springer Singapore
Published in
Surgery Today / Issue 7/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-018-1641-z

Other articles of this Issue 7/2018

Surgery Today 7/2018 Go to the issue

Original Article

Postpneumonectomy bronchopleural fistula in non-small cell lung cancer patients: incidence, survival, mortality, and treatment analysis

Original Article

Treatment of mediastinal lymphatic malformation in children: an analysis of a nationwide survey in Japan

Original Article

Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis

Original Article

Application of a commercial single-port device for robotic single-incision distal pancreatectomy: initial experience

Original Article

Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer

Review Article

Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions